Being Brave: Stories of Children with Drug-Resistant Tuberculosis
March 2012 – When it comes to drug-resistant tuberculosis (DR-TB), the global community is failing to “get it right.” Millions of people around the world suffer from this dangerous, yet treatable, infectious disease. Yet, in over a decade, less than…
Childhood TB Advocacy Meeting Presentations
On January 5, 2012, TAG held a Childhood TB Federal Advocacy Meeting in Washington, D.C. The meeting was cosponsored by STOP TB, RESULTS/ACTION, the Center for Global Health Policy, and the American Thoracic Society (ATS). Some of the highlights of the…
Tallying the TB vaccines in Clinical Trials
By Richard Jefferys, with the assistance of Claire Wingfield, Eleonora Jimenez and Javid Syed. 7/1/2011 - The relatively small community of researchers, policymakers and advocates involved in the search for an effective TB vaccine met in Tallinn, Estonia in September,…
2011 TAG Update
TAG’s annual review of progress we’ve made on the the fight to end HIV/AIDS, Viral Hepatitis, and Tuberculosis.
US Government HIV/AIDS Clinical Trial Sites to Accelerate Completion of Phase III TB Drug Trial
TB Alliance's REMox TB program leverages ACTG sites to advance testing of improved TB treatments November 15, 2011, Durban, South Africa— The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases' (NIAID)…
Treatment Action Group Issues Latest Update on Global TB R&D Investment Trends
2010 Report on TB Research Funding Trends
Tuberculosis Research and Development: 2010 Report on Tuberculosis Research Funding trends, 2005-2009: 2nd Edition By Eleonora Jimenez March 2011 - This is the 2nd Edition of the Stop TB Partnership and Treatment Action Group’s 2010 report on funding trends for…